ACTVX | RGVEX | ACTVX / RGVEX | |
Total Expense Ratio | 0.80 | 0.59 | 136% |
Annual Report Gross Expense Ratio | 0.80 | 0.63 | 127% |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 2.607 | 6.624 | 39% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 89.2M | 23.8B | 0% |
Annual Yield % from dividends | 4.91 | 4.08 | 120% |
Returns for 1 year | 8.61 | 2.78 | 310% |
Returns for 3 years | 15.30 | 8.57 | 179% |
Returns for 5 years | 1.74 | -5.94 | -29% |
Returns for 10 years | 18.96 | 6.59 | 288% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 26.28 | 0.04 | +0.16% |
iShares Health Innovation Active ETF | |||
MCR | 6.47 | -0.01 | -0.15% |
MFS Charter Income Trust | |||
RSMC | 26.07 | -0.07 | -0.27% |
Rockefeller U.S. Small-Mid Cap ETF | |||
EOS | 24.05 | -0.15 | -0.63% |
Eaton Vance Enhance Equity Income Fund II | |||
TSLS | 5.68 | -0.06 | -1.05% |
Direxion Daily TSLA Bear 1X Shares |